4-氨基-2,5,6-三氯嘧啶 | 28969-60-0

• 物质功能分类: 医药中间体 - 杂环化合物 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 4-氨基-2,5,6-三氯嘧啶
• 英文名称: 4-amino-2,5,6-trichloropyrimidine
• 英文别名: 2,5,6-Trichloropyrimidin-4-amine
• CAS: 28969-60-0
• 化学式: C₄H₂Cl₃N₃
• mdl: MFCD09744035
• 分子量: 198.439
• InChiKey: GLDNZPLPEYLLNS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  51.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933599090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  2-8°C

反应信息

• 作为反应物：
  描述：

  4-氨基-2,5,6-三氯嘧啶 在 氨 、 水 作用下， 生成 5-氯-嘧啶-2,4,6-三胺
  参考文献：
  名称：

  Chloroaminopyrimidines

  摘要：

  DOI：

  10.1021/ja01165a504
• 作为产物：
  描述：

  4-氨基-2,6-二氯嘧啶 在 N-氯代丁二酰亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以80%的产率得到4-氨基-2,5,6-三氯嘧啶
  参考文献：
  名称：

  [EN] 4 - AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2A RECEPTOR ANTAGONISTS
  [FR] DÉRIVÉS DE 4-AMINOPYRIMIDINE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DES RÉCEPTEURS DE L'ADÉNOSINE A2A

  摘要：

  公开号：

  WO2011121418A9

文献信息

• Mechanisms for reactions of halogenated compounds. Part 4.[1] activating influences of ring-nitrogen and trifluoromethyl in nucleophilic aromatic substitution
  作者：R.D. Chambers、P.A. Martin、J.S. Waterhouse、D.L.H. Williams、B. Anderson

  DOI：10.1016/s0022-1139(00)82276-9

  日期：1982.6

  determined. Ring-nitrogen activates the system at points ortho-, meta- and para- to the point of substitution, in the ratios ortho- 6.2 × 104, meta- 8.5 × 102, and para- 2.3 × 105. Similarly a trifluoromethyl substituent is activating by a factor of 2.4 × 103 ortho- and 4.5 × 103 para- to the point of substitution.

  已经测量了氨与各种氟化吡啶和二嗪在二恶烷水溶液中在25°下的反应速率常数。从结果确定了环氮（相对于CH）和三氟甲基（相对于-H）的活化作用。环氮在邻位点，间位点和对位点对位激活系统，比例为邻位6.2×10 4，间位8.5×10 2和对位2.3×10 5。类似地，三氟甲基取代基在取代点附近以2.4×10 3的邻位因子和4.5×10 3的因子被激活。
• Prodrugs of hiv replication inhibiting pyrimidines
  申请人：——

  公开号：US20030186990A1

  公开（公告）日：2003-10-02

  The present invention concerns compounds of formula (A 1 )(A 2 )N—R 1 (I),the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and stereochemically isomeric forms thereof, wherein R 1 is substituted C 1-6 alkyl; —S(═O)—R 8 ; —S(═O) 2 —R 8 ; C 7-12 alkylcarbonyl; optionally substituted C 1-6 alkyloxycarbonylC 1-6 alkylcarbonyl; with R 8 being C 1-6 alkyl, aryl 1 or Het 1 ; (A 1 )(A 2 )N— is the covalently bonded form of the corresponding intermediate of formula (A 1 )(A 2 )N—H, which is a HIV replication inhibiting pyrimidine of formula 1

  该发明涉及化合物的公式(A1)(A2)N—R1(I)，其N-氧化物形式、药用可接受的附加盐、季铵盐和立体化学异构体形式，其中R1为取代的C1-6烷基；—S(═O)—R8；—S(═O)2—R8；C7-12烷基羰基；可选择地取代的C1-6烷氧羰基C1-6烷基羰基；其中R8为C1-6烷基、芳基或Het1；(A1)(A2)N—为公式(A1)(A2)N—H对应中间体的共价结合形式，该中间体为公式1的HIV复制抑制嘧啶。
• HIV REPLICATION INHIBITING PYRIMIDINES
  申请人：——

  公开号：US20030114472A1

  公开（公告）日：2003-06-19

  This invention concerns the use of compounds of formula 1 the N-oxides, the pharmaceutically acceptable addition salts, quaternary amines and the stereochemically isomeric forms thereof, wherein -a 1 =-a 2 -a 3 =a 4 - forms a phenyl, pyridinyl, pyrimidinyl, pyridazinyl or pyrazinyl with the attached vinyl group; n is 0 to 4; and where possible 5; R 1 is hydrogen, aryl, formyl, C 1-6 alkylcarbonyl, C 1-6 alkyl, C 1-6 alkyloxy-carbonyl, substituted C 1-6 alkyl, or substituted C 1-6 alkyloxyC 1-6 alkylcarbonyl; each R 2 independently is hydroxy, halo, optionally substituted C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl, C 3-7 cycloalkyl, C 1-6 alkyloxy, C 1-6 alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C 1-6 alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalo-methylthio, —S(═O) p R 6 , —NH—S(═O) p R 6 , —C(═O)R 6 , —NHC(═O)H, —C(═O)NHNH 2 , —NHC(═O)R 6 , —C(═NH)R 6 or a 5-membered heterocyclic ring; p is 1 or 2; L is optionally substituted C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl or C 3-7 cycloalkyl; or L is —X—R 3 wherein R 3 is optionally substituted phenyl, pyridinyl, pyrimidinyl, pyrazinyl or pyridazinyl; X is —NR 1 —, —NH—NH—, —N═N—, —O—, —C(═O)—, —CHOH—, —S—, —S(═O)— or —S(═O) 2 —; Q is hydrogen, C 1-6 alkyl, halo, polyhalo-C 1-6 alkyl or an optionally substituted amino group; Y represents hydroxy, halo, C 3-7 cycloalkyl, optionally substituted C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl, C 1-6 alkyloxy, C 1-6 alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C 1-6 alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, —S(═O) p R 6 , —NH—S(═O) p R 6 , —C(═O)R 6 , —NHC(═O)H, —C(═O)NHNH 2 , —NHC(═O)R 6 , —C(═NH)R 6 or aryl; aryl is optionally substituted phenyl; Het is an optionally substituted heterocyclic radical; for the manufacture of a medicine for the treatment of subjects suffering from HIV (Human Immunodeficiency Virus) infection.

  这项发明涉及使用式1化合物，其N-氧化物，药用可接受的加成盐，季铵盐和其立体化学异构体，其中-a1=-a2-a3=a4-形成苯基，吡啶基，嘧啶基，吡啉基或吡嗪基与附加的乙烯基；n为0至4；如可能为5；R1为氢，芳基，甲酰基，C1-6烷基羰基，C1-6烷基，C1-6烷氧羰基，取代的C1-6烷基，或取代的C1-6烷氧基烷基羰基；每个R2独立地为羟基，卤素，可选地取代的C1-6烷基，C2-6烯基或C2-6炔基，C3-7环烷基，C1-6烷氧基，C1-6烷氧羰基，羧基，氰基，硝基，氨基，单或双(C1-6烷基)氨基，多卤甲基，多卤甲氧基，多卤甲硫基，—S(═O)pR6，—NH—S(═O)pR6，—C(═O)R6，—NHC(═O)H，—C(═O)NHNH2，—NHC(═O)R6，—C(═NH)R6或5-成员杂环环；p为1或2；L为可选地取代的C1-10烷基，C2-10烯基，C2-10炔基或C3-7环烷基；或L为—X—R3，其中R3为可选地取代的苯基，吡啶基，嘧啶基，吡嗪基或吡啉基；X为—NR1—，—NH—NH—，—N═N—，—O—，—C(═O)—，—CHOH—，—S—，—S(═O)—或—S(═O)2—；Q为氢，C1-6烷基，卤素，多卤C1-6烷基或可选地取代的氨基；Y代表羟基，卤素，C3-7环烷基，可选地取代的C1-6烷基，C2-6烯基或C2-6炔基，C1-6烷氧基，C1-6烷氧羰基，羧基，氰基，硝基，氨基，单或双(C1-6烷基)氨基，多卤甲基，多卤甲氧基，多卤甲硫基，—S(═O)pR6，—NH—S(═O)pR6，—C(═O)R6，—NHC(═O)H，—C(═O)NHNH2，—NHC(═O)R6，—C(═NH)R6或芳基；芳基为可选地取代的苯基；Het为可选地取代的杂环基团；用于制造治疗感染艾滋病毒（Human Immunodeficiency Virus）的患者的药物。
• Certain diazines as plant pesticides
  申请人：Imperial Chemical Industries Limited

  公开号：US03974276A1

  公开（公告）日：1976-08-10

  Compositions and methods for combatting insects, fungal and bacterial plant pests are disclosed wherein the active ingredient is a compound of the formula Z--NH--Y wherein X is selected from the group consisting of a pyrazinyl radical bearing one to three substitutents, and pyrimidinyl and pyridazinyl radicals bearing two to three substituents; and Y represents phenyl, naphthyl, pyridyl or diazinyl bearing at least one substituent; the substituents in each case selected from the group consisting of halogen, cyano, nitro, trifluoromethyl, lower alkoxy, lower alkylthio, benzylthio, lower alkyl and amino, provided that (a) the compound bears at least four substituents of which at least two are halogen atoms, and (b) where X represents a pyrimidinyl radical and Y represents a pyridyl radical there is at least one substituent other than halogen present.

  揭示了用于对抗昆虫、真菌和细菌植物害虫的组合物和方法，其中活性成分是一种具有Z--NH--Y公式的化合物，其中X从含有一个至三个取代基的吡嗪基团、含有两至三个取代基的嘧啶基团和吡啶并嘧啶基团中选择；Y代表苯基、萘基、吡啶基或二氮杂吡啶基，至少带有一个取代基；每种情况下的取代基从卤素、氰基、硝基、三氟甲基、低烷氧基、低烷基硫基、苄硫基、低烷基和氨基组成的基团中选择，前提是(a) 该化合物至少带有四个取代基，其中至少两个是卤素原子，以及(b) 当X代表嘧啶基团且Y代表吡啶基团时，存在至少一个不是卤素的取代基。
• REACTIVE LEUCO COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
  申请人：Milliken & Company

  公开号：US20180118942A1

  公开（公告）日：2018-05-03

  A leuco composition comprises at least one reactive leuco compound, which reactive leuco compound comprises a leuco moiety and at least one reactive moiety covalently bound to the leuco moiety. A laundry care composition comprises a laundry care ingredient and a leuco composition. A method of treating a textile comprises the steps of (i) treating a textile with an aqueous solution containing a leuco composition, (ii) optionally, rinsing the textile, and (iii) drying the textile.

  一种白色组合物包括至少一种反应性白色化合物，所述反应性白色化合物包括白色基团和至少一个与白色基团共价结合的反应性基团。一种洗涤护理组合物包括洗涤护理成分和白色组合物。一种处理纺织品的方法包括以下步骤：(i) 用含有白色组合物的水溶液处理纺织品，(ii) 可选地，冲洗纺织品，以及(iii) 干燥纺织品。